Scientists test high dose of monthly HIV pill for heart safety
NCT ID NCT07063238
Summary
This early-stage study tested whether a very high dose of a new monthly oral pill for preventing HIV infection could affect heart rhythm. It involved 42 healthy adult volunteers to check for safety signals, particularly any changes to the electrical activity of the heart. The main goal was to see if the high dose caused a specific, concerning change in heart rhythm more than a placebo did.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hassman Research Institute Marlton Site ( Site 0001)
Marlton, New Jersey, 08053, United States
Conditions
Explore the condition pages connected to this study.